©The Author(s) 2021.
World J Gastrointest Oncol. Sep 15, 2021; 13(9): 1184-1195
Published online Sep 15, 2021. doi: 10.4251/wjgo.v13.i9.1184
Published online Sep 15, 2021. doi: 10.4251/wjgo.v13.i9.1184
Table 3 Comparison of predictive performances between different pathological classifications and prognostic models
| Pathological classification/prognostic model | AUC (95%CI) | AIC | |
| 3-yr overall survival | 5-yr overall survival | ||
| Differentiation grade | 0.626 (0.608–0.644) | 0.621 (0.602–0.639) | 25971 |
| Lauren classification | 0.666 (0.647–0.683) | 0.681 (0.663–0.699) | 25923 |
| Modified Lauren classification | 0.679 (0.661–0.696) | 0.702 (0.685–0.719) | 25877 |
| DeLong tests for AUCs | |||
| Differentiation grade vs Lauren | P < 0.001 | P < 0.001 | – |
| Lauren vs modified Lauren | P < 0.001 | P < 0.001 | – |
| Modified Lauren vs differentiation grade | P < 0.001 | P < 0.001 | – |
| Novel prognostic model | 0.803 (0.786–0.819) | 0.804 (0.787–0.820) | 20010 |
| Age, tumor size, retrieved lymph nodes, pT stage, pN stage, modified Lauren classification | |||
| Control model | 0.776 (0.759–0.793) | 0.776 (0.759–0.793) | 20144 |
| AJCC 8th pTNM stage (pT stage, pN stage) | |||
- Citation: Ning FL, Zhang NN, Wang J, Jin YF, Quan HG, Pei JP, Zhao Y, Zeng XT, Abe M, Zhang CD. Prognostic value of modified Lauren classification in gastric cancer. World J Gastrointest Oncol 2021; 13(9): 1184-1195
- URL: https://www.wjgnet.com/1948-5204/full/v13/i9/1184.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i9.1184